VHL
About
Location: 3p25.3
Mappings
Biomarkers
VHL is involved in the following curated biomarkers.
| Name | Biomarker type | Propositions | Statements |
|---|---|---|---|
| VHL pathogenic variants | Germline Variant | 3 | 6 |
Therapeutic response
Precision oncology relationships for therapeutic response involving this gene.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | VHL pathogenic variants | Renal Cell Carcinoma | Belzutifan | |
| EMA (1) FDA (1) | VHL pathogenic variants | Central Nervous System Hemangioblastoma | Belzutifan | |
| EMA (1) FDA (1) | VHL pathogenic variants | Pancreatic Neuroendocrine Tumor | Belzutifan |